CD38 and Glucose intolerance: The beneficial effects of apigenin on glucose and lipid metabolism are quite established, since apigenin improves glucose intolerance in miRNA103-overexpressing transgenic mice [108] and increases NAD+ levels through inhibition of cluster of differentiation 38 (CD38) in obese mice, ameliorating glucose and lipid homeostasis [109].